8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), 50 mL vials, Rx Supply Disruption — Exela Pharma Sciences LLC (Mod
8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), 50 mL vials, Rx Supply Disruption — Exela Pharma Sciences LLC (Mod is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), 50 mL vials, Rx; Manufacturer: Exela
| Drug name | 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), 50 mL vials, Rx |
|---|---|
| Manufacturer | Exela Pharma Sciences LLC |
| Recall/Disruption reason | Lack of Assurance of Sterility |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-0369-2022 |
| Initiation date | 20220111 |
| Quantity affected | 18,960 vials |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →